Green Cures & Botanical Distribution Inc
Global Roundtable Corporation provides health and wellness services and products. The company was formerly known as Green Cures & Botanical Distribution Inc. and changed its name to Global Roundtable Corporation in May 2023. Global Roundtable Corporation was incorporated in 1986 and is based in Denver, Colorado.
Green Cures & Botanical Distribution Inc (GRCU) - Net Assets
Latest net assets as of December 2024: $656.12K USD
Based on the latest financial reports, Green Cures & Botanical Distribution Inc (GRCU) has net assets worth $656.12K USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.03 Million) and total liabilities ($1.38 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $656.12K |
| % of Total Assets | 32.24% |
| Annual Growth Rate | N/A |
| 5-Year Change | 1046.05% |
| 10-Year Change | N/A |
| Growth Volatility | 46.54 |
Green Cures & Botanical Distribution Inc - Net Assets Trend (2005–2024)
This chart illustrates how Green Cures & Botanical Distribution Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Green Cures & Botanical Distribution Inc (2005–2024)
The table below shows the annual net assets of Green Cures & Botanical Distribution Inc from 2005 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $656.12K | -8.93% |
| 2023-12-31 | $720.42K | +464.54% |
| 2022-12-31 | $-197.62K | -4189.67% |
| 2021-12-31 | $-4.61K | -108.05% |
| 2020-12-31 | $57.25K | +338.01% |
| 2019-12-31 | $-24.05K | +93.47% |
| 2018-12-31 | $-368.39K | -14.67% |
| 2017-12-31 | $-321.27K | -3.44% |
| 2016-12-31 | $-310.59K | -2210.11% |
| 2015-12-31 | $-13.45K | +91.53% |
| 2014-12-31 | $-158.67K | -100.47% |
| 2011-12-31 | $33.95 Million | +396.13% |
| 2010-12-31 | $-11.47 Million | -120.88% |
| 2009-12-31 | $54.91 Million | +686.85% |
| 2008-12-31 | $-9.36 Million | -562.72% |
| 2007-12-31 | $-1.41 Million | -145.67% |
| 2006-12-31 | $3.09 Million | +35990.68% |
| 2005-12-31 | $-8.61K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Green Cures & Botanical Distribution Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 126092300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.23 Million | 1101.44% |
| Total Equity | $656.12K | 100.00% |
Green Cures & Botanical Distribution Inc Competitors by Market Cap
The table below lists competitors of Green Cures & Botanical Distribution Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mera Pharmaceuticals Inc
PINK:MRPI
|
$1.00 |
|
Equal Trading Inc
PINK:EQTD
|
$1.00 |
|
Foy Johnston Inc
PINK:FOYJ
|
$1.00 |
|
Alliance Media Holdings Inc
PINK:ADTR
|
$1.00 |
|
Global Environmental Energy Corp
PINK:GEECF
|
$1.00 |
|
Flameret Inc
PINK:FLRE
|
$1.00 |
|
International Silver Inc
PINK:ISLV
|
$1.00 |
|
Beamz Interactive
PINK:BZIC
|
$1.00 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Green Cures & Botanical Distribution Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 734,419 to 656,117, a change of -78,302 (-10.7%).
- Net loss of 243,229 reduced equity.
- Other comprehensive income increased equity by 6,079,419.
- Other factors decreased equity by 5,914,492.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-243.23K | -37.07% |
| Other Comprehensive Income | $6.08 Million | +926.58% |
| Other Changes | $-5.91 Million | -901.44% |
| Total Change | $- | -10.66% |
Book Value vs Market Value Analysis
This analysis compares Green Cures & Botanical Distribution Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.06x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | $0.00 | $0.00 | x |
| 2016-12-31 | $0.00 | $0.00 | x |
| 2019-12-31 | $0.00 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
| 2023-12-31 | $0.00 | $0.00 | x |
| 2024-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Green Cures & Botanical Distribution Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -37.07%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -18.71%
- • Asset Turnover: 0.64x
- • Equity Multiplier: 3.10x
- Recent ROE (-37.07%) is above the historical average (-625.61%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-20.83K |
| 2006 | -211.93% | 0.00% | 0.00x | 1.09x | $-6.86 Million |
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-12.38 Million |
| 2008 | 0.00% | -1603814.52% | 0.00x | 0.00x | $-9.01 Million |
| 2009 | -163.57% | -3087520.48% | 0.00x | 1.68x | $-69.92 Million |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $2.03 Million |
| 2011 | 0.00% | 496.44% | 0.03x | 0.00x | $6.58 Million |
| 2014 | 0.00% | -315.42% | 6.33x | 0.00x | $-219.78K |
| 2015 | 0.00% | -473.37% | 0.29x | 0.00x | $-94.27K |
| 2016 | 0.00% | -40875.68% | 16.75x | 0.00x | $-2.75 Million |
| 2017 | 0.00% | 45.69% | 113.41x | 0.00x | $83.73K |
| 2018 | 0.00% | 46.84% | 29.57x | 0.00x | $71.12K |
| 2019 | 0.00% | 34.49% | 47.05x | 0.00x | $65.47K |
| 2020 | 17.67% | 5.28% | 0.36x | 9.21x | $4.39K |
| 2021 | -10921.81% | -383.30% | 0.22x | 131.56x | $-521.23K |
| 2022 | 0.00% | -442.82% | 0.17x | 0.00x | $-432.28K |
| 2023 | 55.67% | 17.36% | 1.34x | 2.39x | $335.38K |
| 2024 | -37.07% | -18.71% | 0.64x | 3.10x | $-308.84K |
Industry Comparison
This section compares Green Cures & Botanical Distribution Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Green Cures & Botanical Distribution Inc (GRCU) | $656.12K | 0.00% | 2.10x | $1.00 |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |